Bispezifische Antikörper auch nach CAR-T-Zellen oder als Bridging-Therapie anwendbar
Crossref DOI link: https://doi.org/10.1007/s15015-020-2335-0
Published Online: 2020-02-07
Published Print: 2020-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Siegmund-Schultze, Nicola
Text and Data Mining valid from 2020-02-01
Version of Record valid from 2020-02-01
Article History
First Online: 7 February 2020
Free to read: This content has been made available to all.